Putnam BioRevolution ETF (SYNB)
AMEX: SYNB
· Real-Time Price · USD
30.41
0.14 (0.45%)
At close: Sep 08, 2025, 3:58 PM
0.45% (1D)
| Bid | 30.39 |
| Market Cap | 5.35M |
| AUM | 5.3M |
| NAV | 30.27 |
| EPS (ttm) | 0.97 |
| PE Ratio (ttm) | 31.41 |
| Shares Out | 167.52K |
| Inception Date | Sep 29, 2022 |
| Ask | 30.46 |
| Volume | 0 |
| Open | 30.19 |
| Previous Close | 30.27 |
| Day's Range | 30.16 - 30.42 |
| 52-Week Range | 24.57 - 33.23 |
| Holdings | 38 |
| Expense Ratio | 0.70% |
About SYNB
The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.
Asset Class Equity
Ticker Symbol SYNB
Inception Date Sep 29, 2022
Provider Putnam
Website Fund Home Page
Exchange AMEX
Top Sectors
| Sector | Weight % |
|---|---|
| Healthcare | 59.68% |
| Basic Materials | 23.72% |
| Technology | 9.00% |
| Consumer Defensive | 5.81% |
| Consumer Cyclical | 1.80% |
Top 10 Holdings 45.45% of assets
| Name | Symbol | Weight |
|---|---|---|
| Corteva, Inc. | CTVA | 5.94% |
| Abbvie Inc. | ABBV | 5.39% |
| Novozymes A/s | NVZMY | 4.94% |
| Ascendis Pharma A/s | ASND | 4.74% |
| Astrazeneca PLC | AZN | 4.54% |
| Nvidia Corporation | NVDA | 4.47% |
| Bio-rad Laboratories... | BIO | 4.44% |
| Cadence Design Syste... | CDNS | 4.00% |
| Icon Public Limited ... | ICLR | 3.50% |
| Eli Lilly And Compan... | LLY | 3.49% |
Dividends Dividend Yield 0.7%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 5, 2024 | $0.2139 | Dec 9, 2024 |
| Dec 6, 2023 | $0.0211 | Dec 11, 2023 |
